EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of Plasma Metabolites and Cardiac Mitochondrial Function with Heart Failure Progression

Vandana Revathi Venkateswaran iD, Ruicong She, Stephen J Gardell, Jasmine A Luzum, Ramesh Gupta, Kefei Zhang, L Keoki Williams, Hani N Sabbah, David E Lanfear

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Vandana Revathi Venkateswaran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Individualized and Genomic Medicine Research (CIGMA), Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Heart Failure, Mitochondria, Heart, Ventricular Remodeling, Stroke Volume. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMHD NIH HHS, NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Plasma metabolites are prognostic in heart failure with reduced ejection fraction (HFrEF), with citric acid cycle metabolites linked to ejection fraction (EF) changes. We investigated these mechanisms in a canine chronic HFrEF model. We tested associations between changes in plasma metabolites, left ventricular (LV) end-diastolic volume and cardiomyocyte mitochondrial function.

Methods

Eighteen dogs underwent microembolization to induce moderate HFrEF (target LVEF 35%–40%). Plasma metabolites, LV size and mitochondrial function were assessed over 12 months.

Results

Plasma metabolite heatmap showed acylcarnitine changes, with early alterations in organic acids and amino acids predicting later adverse LV remodelling. Using either baseline or change over time, 13 metabolites correlated with 12 month LV enlargement. This is mostly often at 3 months (11 of 13), notably C18:2 (r = −0.58, P = 0.003) and cardiac anaplerotic substrates like glutamine (r = −0.52, P = 0.009) and 3-HBA (r = −0.43, P = 0.035). Impaired cardiomyocyte mitochondrial function correlated with LV enlargement (max ATP synthesis 12.7 vs. 19.9 nmol/min/mg, P = 0.0036; ADP-stimulated respiration 224 vs. 308 nAtom O/min/mg protein; P = 0.0064). Plasma metabolites correlated with mitochondrial parameters at 12 month, particularly with MAX ATP: malate (r = −0.75, P < 0.001), fumarate (r = −0.6, P = 0.008) and glutamine (r = 0.51, P = 0.031).

Conclusions

In canine HFrEF, plasma acylcarnitines, citric acid cycle or anaplerotic metabolites predicted adverse LV remodelling. LV enlargement correlated with reduced cardiomyocyte mitochondrial function, which in turn was also associated with increased citric acid cycle metabolites. Together, these data suggest impaired cardiac energetic function drives plasma metabolite associations in HFrEF progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMitochondria, HeartVentricular RemodelingStroke VolumeMyocytes, CardiacVentricular Function, LeftAnimalsDogsDisease ProgressionDisease Models, AnimalCarnitineMaleBiomarkersFemaleCitric Acid Cycle

Stichwörter der Autor:innen

cardiac mitochondrial progressionheart failureplasma metaboliteplasma metabolomic profiling

Substanzen

CarnitineBiomarkers

Autor:innen und Institutionen

  • Center for Individualized and Genomic Medicine Research (CIGMA), Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
  • Department of Public Health Sciences, Henry Ford Hospital, Detroit, Michigan, USA.
  • AdventHealth Translational Research Institute, Orlando, Florida, USA.
  • Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
  • Division of Cardiovascular Medicine, Department of Medicine, Henry Ford Hospital, Henry Ford Health, Detroit, Michigan, USA.

ORCID-Profile: Vandana Revathi Venkateswaran

Förderung

  • NIMHD NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • NIH

Zitieren

APA

Venkateswaran, V. R., She, R., Gardell, S. J., Luzum, J. A., Gupta, R., Zhang, K., Williams, L. K., Sabbah, H. N., & Lanfear, D. E. (2025). Association of Plasma Metabolites and Cardiac Mitochondrial Function with Heart Failure Progression. ESC Heart Failure. https://doi.org/10.1002/ehf2.15215

Vancouver

Venkateswaran VR, She R, Gardell SJ, Luzum JA, Gupta R, Zhang K, et al. Association of Plasma Metabolites and Cardiac Mitochondrial Function with Heart Failure Progression. ESC Heart Failure. 2025. doi:10.1002/ehf2.15215

BibTeX
@article{Venkateswaran2025,
  author = {Venkateswaran, Vandana Revathi and She, Ruicong and Gardell, Stephen J and Luzum, Jasmine A and Gupta, Ramesh and Zhang, Kefei and Williams, L Keoki and Sabbah, Hani N and Lanfear, David E},
  title = {Association of Plasma Metabolites and Cardiac Mitochondrial Function with Heart Failure Progression},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15215}
}
Kostenlos starten →